focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,118.00
Bid: 12,118.00
Ask: 12,122.00
Change: -54.00 (-0.44%)
Spread: 4.00 (0.033%)
Open: 12,180.00
High: 12,188.00
Low: 12,096.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks finish lower as ECB stands pat

Thu, 11th Apr 2024 15:56

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

The FTSE 100 closed down 0.47% at 7,923.80 points, while the FTSE 250 experienced a marginal decline of 0.08%, closing at 19,786.87 points.

In currency markets, sterling was last down 0.06% on the dollar, trading at $1.2532, while it strengthened 0.18% against the euro to change hands at €1.1693.

"The FTSE 100 saw a slight increase [earlier] as investors shifted their attention from the higher-than-expected US inflation data to the European Central Bank's interest rate decision," said TickMill market analyst Patrick Munnelly.

"The internationally-focused index saw a slight decline post the ECB announcement, where it held the bank rate at 4%.

"ECB president Christine Lagarde did not commit to a specific policy path."

Munnelly said the ECB's statement indicated that if inflation and monetary policy transmission increased confidence in returning price growth to target, it would be appropriate to reduce monetary policy restrictions.

"Investors inferred that means a rate cut in June is likely.

"However, president Lagarde's comments during the post-meeting press conference left traders uncertain about the future development of policy after June."

Wholesale prices rise modestly in the US, ECB stands pat on rates

In economic news, US wholesale prices saw a modest increase last month, falling slightly short of expectations.

The Department of Labor reported a 0.2% month-on-month rise in seasonally adjusted total final demand prices in March, with food prices climbing by 0.8%.

However, energy prices experienced a 1.6% decline, serving as a partial offset.

On a year-on-year basis, producer prices were up by 2.1%, indicating a steady yet moderate pace of inflation.

"After another sizzling CPI report, producer prices offer some relief for Fed officials who may view the recent price reports as too hot to consider rate cuts in the immediate future," said Matthew Martin, US economist at Oxford Economics.

"While we see the odds of the first rate cut occurring in September rising, cooler reports such as the PPI report keep the June meeting on the table, which is our current baseline."

Meanwhile, initial jobless claims in the US dropped to 211,000 in the week ended 6 April, marking the lowest reading in a month and undershooting market expectations, while continuing claims also decreased.

Closer to home, the European Central Bank (ECB) opted to maintain its current interest rates, signalling a cautious approach amid uncertainties surrounding inflation and geopolitical events.

ECB president Christine Lagarde emphasised the potential impact of geopolitical tensions on economic growth and prices, acknowledging the importance of energy price fluctuations in shaping inflation dynamics.

The ECB's stance remained contingent on future economic projections, with a willingness to adjust interest rates if needed to support price stability.

On home shores, the UK housing market showed signs of resilience, with buyer demand strengthening and house price trends improving.

According to the RICS UK residential survey, buyer demand reached its most positive level since February 2022 in March, while new instructions also increased.

House price trends continued to improve for the seventh consecutive month, indicating a stabilising market despite ongoing uncertainties.

"Demand continues to recover gradually across the UK housing market, with new buyer enquiries rising for a third month in succession," said Tarrant Parsons, senior economist at the Royal Institution of Chartered Surveyors.

"With the inflation backdrop turning a little less difficult of late, this has led to expectations that the Bank of England will be able to start lowering interest rates later in the year.

"This should continue to support the market to a certain degree going forward."

Ex-divs prove a big drag, Kingfisher rises on upgrade

On London's equity markets, ex-dividend stocks proved a major drag, with Aviva, Barratt Developments, Lloyds, Reckitt Benckiser, Phoenix Group, Smurfit Kappa, Man Group, Howden Joinery, Just Group, Savills, TP ICAP, Harbour Energy, Hunting and ITV all in the red as a result.

Travel shares were under pressure amid concerns over potential geopolitical tensions, with IAG, easyJet, Carnival, and Wizz Air Holdings all registering losses.

Jupiter Fund Management faced downward pressure following a downgrade from Barclays.

On the upside, B&Q and Castorama owner Kingfisher rose 2.44% after receiving an upgrade to 'buy' from HSBC.

AstraZeneca increased 2.14% after announcing a 7% rise in its annual dividend, while Great Portland Estates added 1.61% on the back of strong demand and expectations of a rate cut.

Cybersecurity specialist Darktrace jumped 5.82% after raising its guidance for the year following robust third-quarter results.

Elsewhere, Marks & Spencer received a boost after an upgrade from JPMorgan, while outside the FTSE 250, Lok'n Store Group rocketed 16.91% following an acquisition agreement with Belgian rival Shurgard.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 7,923.80 -0.47%

FTSE 250 (MCX) 19,786.87 -0.08%

techMARK (TASX) 4,458.35 0.37%

FTSE 100 - Risers

Centrica (CNA) 130.30p 3.41%

Smiths Group (SMIN) 1,647.00p 2.68%

Kingfisher (KGF) 248.00p 2.44%

AstraZeneca (AZN) 10,962.00p 2.14%

Rightmove (RMV) 535.80p 1.90%

Unite Group (UTG) 937.50p 1.68%

Hikma Pharmaceuticals (HIK) 1,817.00p 1.62%

Imperial Brands (IMB) 1,701.50p 1.58%

SSE (SSE) 1,605.50p 1.32%

Intermediate Capital Group (ICP) 2,114.00p 1.25%

FTSE 100 - Fallers

Aviva (AV.) 458.80p -6.35%

Phoenix Group Holdings (PHNX) 511.00p -5.81%

Tesco (TSCO) 282.00p -5.05%

Lloyds Banking Group (LLOY) 50.66p -4.63%

International Consolidated Airlines Group SA (CDI) (IAG) 169.10p -3.67%

easyJet (EZJ) 547.20p -3.61%

Barclays (BARC) 183.64p -3.08%

Sainsbury (J) (SBRY) 259.80p -2.77%

HSBC Holdings (HSBA) 646.70p -2.49%

Reckitt Benckiser Group (RKT) 4,206.00p -2.30%

FTSE 250 - Risers

Darktrace (DARK) 466.20p 6.25%

Watches of Switzerland Group (WOSG) 373.00p 5.13%

Safestore Holdings (SAFE) 760.50p 4.54%

Drax Group (DRX) 497.20p 2.90%

Close Brothers Group (CBG) 483.40p 2.68%

Bytes Technology Group (BYIT) 510.00p 2.57%

Big Yellow Group (BYG) 1,044.00p 2.55%

Diversified Energy Company (DEC) 1,106.00p 2.50%

Centamin (DI) (CEY) 127.90p 2.32%

Workspace Group (WKP) 509.00p 2.22%

FTSE 250 - Fallers

TUI AG Reg Shs (DI) (TUI) 646.00p -4.58%

Man Group (EMG) 264.60p -3.85%

TP Icap Group (TCAP) 214.00p -3.83%

Savills (SVS) 1,020.00p -3.77%

W.A.G Payment Solutions (WPS) 68.80p -3.46%

ITV (ITV) 70.70p -3.42%

Wizz Air Holdings (WIZZ) 2,280.00p -3.14%

Jupiter Fund Management (JUP) 87.70p -3.09%

Carnival (CCL) 1,062.50p -2.88%

Aston Martin Lagonda Global Holdings (AML) 159.80p -2.80%

More News
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.